Document is current

Article History

Accepted: 23 July 2024

First Online: 27 August 2024

Competing interests

: J.B. has acted as a consultant of MSD. D.K. has acted as a consultant and/or adviser of Agilent, AstraZeneca, BMS, Illumina, Incyte, Eli Lilly, Pfizer and Takeda. C.S. has acted as a consultant of MSD and has received speaker’s fees from Bayer Vital and Boehringer Ingelheim. P.S. has acted as a consultant of BMS, Eisai, Incyte, Janssen, MSD and Roche and has received research funding from BMS, Chugai and Incyte. S.P. has acted as a consultant and/or adviser of AbbVie, Amgen, Arcus, AstraZeneca, Bayer, Beigene, BerGenBio, Biocartis, BioInvent, Blueprint Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F-Star, Fishawack, Foundation Medicine, Genzyme, Gilead, GlaxoSmithKline, Hutchmed, Illumina, Incyte, Ipsen, iTeos, Janssen, Merck Sharp & Dohme, Merck Serono, Merrimack, Mirati, Nykode Therapeutics, Novartis, Novocure, Pharma Mar, Promontory Therapeutics, Pfizer, Regeneron, Roche/Genentech, Sanofi, Seattle Genetics and Takeda; holds a board of director position for Galenica; has acted as a speaker for AstraZeneca, Boehringer Ingelheim, BMS, Eli Lilly, Foundation Medicine, GlaxoSmithKline, Illumina, Ipsen, Merck Sharp & Dohme, Mirati, Novartis, Pfizer, Roche/Genentech, Sanofi and Takeda; and has acted as a principal investigator in trials sponsored by Amgen, Arcus, AstraZeneca, Beigene, Bristol-Myers Squibb, GlaxoSmithKline, iTeos, Merck Sharp & Dohme, Mirati, Pharma Mar, Promontory Therapeutics, Roche/Genentech and Seattle Genetics. A.K. has acted as a consultant and/or adviser, received support for attending meetings and/or travel, participated in a data safety monitoring board and received research funding from F. Hoffmann-La Roche and has received research funding from BMS and Molecular Health. P.C. has acted as a consultant and/or adviser of AstraZeneca, Boehringer Ingelheim, Chugai, Pfizer, Novartis, MSD, Takeda and Roche; has acted as a speaker for AstraZeneca, Janssen, Novartis, Roche, Pfizer, Thermo Fisher and Takeda; has received research funding from AstraZeneca, Amgen, Boehringer Ingelheim, Novartis, Roche and Takeda; and has received travel support from AstraZeneca, Eli Lilly, Daiichi Sankyo, Gilead, Novartis, Pfizer and Takeda. A.S. has acted as an adviser and/or speaker for Agilent, Aignostics, Amgen, Astellas, AstraZeneca, Bayer, BMS, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, QuIP, Roche, Sanofi, Seagen, Servier, Takeda and Thermo Fisher Scientific and has received research funding from Bayer, BMS, Chugai, Incyte and MSD.